An Investigation of ReNu Knee Injection: Monitoring the Response of Knee Function and Pain in Patients With Osteoarthritis
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 31 Aug 2017
At a glance
- Drugs Amniotic cell therapy-NuCel (Primary)
- Indications Osteoarthritis
- Focus Therapeutic Use
- Sponsors Nutech Medical
- 24 Aug 2017 Status changed from recruiting to active, no longer recruiting.
- 11 Aug 2016 Planned number of patients changed from 150 to 200.
- 11 Aug 2016 Planned End Date changed from 1 Mar 2017 to 1 Mar 2018.